Eating oysters without risk of vibriosis: Application of a bacteriophage against Vibrio parahaemolyticus in oysters

International Journal of Food Microbiology

Volumn 188, Issue , 2014, Pages 31-35

  Jun, Jin Woo ^a,b   Kim, Hyoun Joong ^b   Yun, Sae Kil ^b   Chai, Ji Young ^c   Park, Se Chang ^b  

^a INSTITUTE OF OCEANOGRAPHY   (Greece)

^b Seoul National University   (South Korea)

^c Bundang Jesaeng Hospital   (South Korea)

Author keywords

Bacteriophage; Multiple antibiotic resistant; Oyster; Pandemic strain; Vibrio parahaemolyticus

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM CONTAMINATION; EATING; HUMAN; IMMERSION; OYSTER; PANDEMIC; RISK; VIBRIO PARAHAEMOLYTICUS; VIBRIO PARAHAEMOLYTICUS INFECTION;

BACTERIOPHAGE; MULTIPLE-ANTIBIOTIC-RESISTANT; OYSTER; PANDEMIC STRAIN; VIBRIO PARAHAEMOLYTICUS;

ANIMALS; AQUACULTURE; BACTERIAL LOAD; BACTERIOPHAGES; FOOD MICROBIOLOGY; FOODBORNE DISEASES; OSTREIDAE; VIBRIO INFECTIONS; VIBRIO PARAHAEMOLYTICUS;

EID: 84905234677     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2014.07.007     Document Type: Article

References (32)

1. Adams M. Bacteriophages 1959, Interscience Publishers, New York.
2. Biswas B., Adhya S., Washart P., Paul B., Trostel A.N., Powell B., Carlton R., Merril C.R. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 2002, 70:204-210.
3. Bruttin A., Brussow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 2005, 49:2874-2878.
4. Call J.E., Porto-Fett A., Luchansky J.B. Effectiveness of Bacteriophage to Control the Outgrowth of Listeria monocytogenes on the Surface of Frankfurters 2008, 2-57. International Association for Food Protection, Columbus, Ohio, (Poster).
5. Carlton R.M., Noordman W.H., Biswas B., de Meester E.D., Loessner M.J. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul. Toxicol. Pharmacol. 2005, 43:301-312.
6. Chhibber S., Kaur S., Kumari S. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J. Med. Microbiol. 2008, 57:1508-1513.
7. Daniels N.A., MacKinnon L., Bishop R., et al. Vibrio parahaemolyticus infections in the United States, 1973-1998. J. Infect. Dis. 2000, 181:1661-1666.
8. Denes T., Wiedmann M. Environmental responses and phage susceptibility in foodborne pathogens: implications for improving applications in food safety. Curr. Opin. Biotechnol. 2014, 26:45-49.
9. Dykes G.A., Moorhead S.M. Combined antimicrobial effect of nisin and a listeriophage against Listeria monocytogenes in broth but not in buffer or on raw beef. Int. J. Food Microbiol. 2002, 73:71-81.
10. Endersen L., O'Mahony J., Hill C., Ross R.P., McAuliffe O., Coffey A. Phage therapy in the food industry. Annu. Rev. Food Sci. Technol. 2014, 5:327-349.
11. González-Escalona N., Cachicas V., Acevedo C., Rioseco M.L., Vergara J.A., Cabello F., Romero J., Espejo R.T. Vibrio parahaemolyticus diarrhea, Chile, 1998 and 2004. Emerg. Infect. Dis. 2005, 11:129-131.
12. Guenther S., Huwyler D., Richard S., Loessner M.J. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl. Environ. Microbiol. 2009, 75:93-100.
13. Hagen S., Offerhaus M.L. Bacteriophages: new weapons for food safety. Food Technol. 2008, 4:46-54.
14. Joseph S.W., Colwell R.R., Kaper J.B. Vibrio parahaemolyticus and related halophilic Vibrios. Crit. Rev. Microbiol. 1982, 10:77-124.
15. Jun J.W., Kim J.H., Choresca C.H., Shin S.P., Han J.E., Han S.Y., Chai J.Y., Park S.C. Isolation, molecular characterization, and antibiotic susceptibility of Vibrio parahaemolyticus in Korean seafood. Foodborne Pathog. Dis. 2012, 9:224-231.
16. Jun J.W., Kim J.H., Shin S.P., Han J.E., Chai J.Y., Park S.C. Protective effects of the Aeromonas phages pAh1-C and pAh6-C against mass mortality of the cyprinid loach (Misgurnus anguillicaudatus) caused by Aeromonas hydrophila. Aquaculture 2013, 416-417:289-295.
17. Jun J.W., Shin T.H., Kim J.H., Shin S.P., Han J.E., Heo G.J., De Zoysa M., Shin G.W., Chai J.Y., Park S.C. Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple antibiotic resistant O3:K6 pandemic clinical strain. J. Infect. Dis. 2014, 10.1093/infdis/jiu059.
18. Kaneko T., Colwell R.R. Incidence of Vibrio parahaemolyticus in Chesapeake Bay. Appl. Microbiol. 1975, 30:251-257.
19. Kim J.H., Jun J.W., Choresca C.H., Shin S.P., Han J.E., Park S.C. Complete genome sequence of a novel marine siphovirus, pVp-1, infecting Vibrio parahaemolyticus. J. Virol. 2012, 86:7013-7014.
20. Kumari S., Harjai K., Chhibber S. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J. Microbiol. Biotechnol. 2009, 19:622-628.
21. Lee D. Viruses and bivalve shellfish. Int. J. Food Microbiol. 2000, 59:81-116.
22. Leverentz B., Conway W.S., Camp M.J., Janisiewicz W.J., Abuladze T., Yang M., Saftner R., Sulakvelidze A. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl. Environ. Microbiol. 2003, 69:4519-4526.
23. Matsumoto C., Okuda J., Ishibashi M., et al. Pandemic spread of an O3:K6 clone of Vibrio parahaemolyticus and emergence of related strains evidenced by arbitrarily primed PCR and toxRS sequence analyses. J. Clin. Microbiol. 2000, 38:578-585.
24. 2 as an agent of warm pasteurization. Int. J. Food Microbiol. 2010, 138:63-70.
25. Miya S., Takahashi H., Ishikawa T., Fujii T., Kimura B. Risk of Listeria monocytogenes contamination of raw ready-to-eat seafood products available at retail outlets in Japan. Appl. Environ. Microbiol. 2010, 76:3383-3386.
26. Nair G.B., Ramamurthy T., Bhattacharya S.K., Dutta B., Takeda Y., Sack D.A. Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants. Clin. Microbiol. Rev. 2007, 20:39-48.
27. Ottaviani D., Leoni F., Rocchegiani E., et al. First clinical report of pandemic Vibrio parahaemolyticus O3:K6 infection in Italy. J. Clin. Microbiol. 2008, 46:2144-2145.
28. Park S.C., Shimamura I., Fukunaga M., Mori K., Nakai T. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl. Environ. Microbiol. 2000, 66:1416-1422.
29. Rong R., Lin H., Wang J., Khan M.N., Li M. Reductions of Vibrio parahaemolyticus in oysters after bacteriophage application during depuration. Aquaculture 2014, 418-419:171-176.
30. Soni K.A., Nannapaneni R., Hagens S. Reduction of Listeria monocytogenes on the surface of fresh channel catfish fillets by bacteriophage Listex P100. Foodborn Pathog. Dis. 2010, 7:427-434.
31. Sulakvelidze A., Kutter E. Bacteriophage therapy in humans. Bacteriophages: Biology and Applications 2005, 381-436. CRC Press, Boca Raton, FL. E. Kutter, A. Sulakvelidze (Eds.).
32. Vinodkumar C.S., Neelagund Y.F., Kalsurmath S. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae. J. Commun. Dis. 2005, 37:18-29.